Alembic Ltd

NSE: ALEMBICLTD · BSE: 506235 · Pharmaceuticals & Biotechnology · 26 announcements

Share price: ₹115.67
Market cap: ₹2,970 Cr
Revenue (annual): ₹240.0 Cr
Net profit (annual): ₹317.4 Cr
P/E (TTM): 8.4×Sector 43.8×
Promoter holding: 71.41%+0.53% QoQ
FII holding: 1.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Buying 8 Other Announcement 4 Financial Results 4 Board Meeting Date 3 Dividend 2 Annual General Meeting 2 Debt & Borrowing 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

28 Oct 2026 12:45 IST BSE

Board Meeting Date

Alembic Board Meeting Date

Alembic Ltd's Board will meet on 6 November 2026 to approve unaudited Q1 and H1 FY27 results. Trading window remains closed until 48 hours post-announcement.

Open announcement → Read the filing ↗

31 Jul 2026 15:39 IST BSE

Board Meeting Date

Alembic Board Meeting Date

Alembic Ltd scheduled a Board Meeting for August 11, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026.

Open announcement → Read the filing ↗

8 May 2026 12:52 IST BSE

Board Meeting Date

Alembic Board Meeting Date

Alembic Ltd's board will meet on May 19, 2026, to approve audited annual results and consider a dividend. This meeting follows the fiscal year end.

Open announcement → Read the filing ↗